NextCure, Inc.
NXTC
$0.3348
$0.00210.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.72M | 16.13M | 17.01M | 18.65M | 19.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.21M | 60.54M | 63.66M | 66.33M | 67.64M |
| Operating Income | -57.21M | -60.54M | -63.66M | -66.33M | -67.64M |
| Income Before Tax | -55.65M | -58.52M | -61.28M | -63.73M | -62.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.65 | -58.52 | -61.28 | -63.73 | -62.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.65M | -58.52M | -61.28M | -63.73M | -62.72M |
| EBIT | -57.21M | -60.54M | -63.66M | -66.33M | -67.64M |
| EBITDA | -54.34M | -57.53M | -60.40M | -62.81M | -63.95M |
| EPS Basic | -1.99 | -2.09 | -2.20 | -2.29 | -2.25 |
| Normalized Basic EPS | -1.19 | -1.25 | -1.32 | -1.37 | -1.41 |
| EPS Diluted | -1.99 | -2.09 | -2.20 | -2.29 | -2.25 |
| Normalized Diluted EPS | -1.19 | -1.25 | -1.32 | -1.37 | -1.41 |
| Average Basic Shares Outstanding | 111.86M | 111.75M | 111.62M | 111.47M | 111.35M |
| Average Diluted Shares Outstanding | 111.86M | 111.75M | 111.62M | 111.47M | 111.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |